Modafinil, sold under the brand name Provigil among others, is a central nervous system (CNS) stimulant medication used to treat narcolepsy, sleep apnea, and shift work sleep disorder. It is taken by mouth. Modafinil is a first-line treatment for narcolepsy in the United States and Europe.
The mechanism of action is not fully understood, but modafinil acts mainly as an atypical dopaminereuptake inhibitor, increasing dopamine levels without the rapid signaling seen with classical stimulants such as amphetamine or cocaine. Unlike these drugs, modafinil has low addiction and dependence potential and does not produce strong euphoria, which contributes to its classification as a Schedule IV controlled substance in the United States. It is a prescription medication in most countries.
Modafinil is generally well-tolerated; common side effects include headache, nausea, anxiety, and insomnia. Rare but serious adverse effects include severe skin reactions such as Stevens-Johnson syndrome. Modafinil is contraindicated during pregnancy due to increased risk of birth defects.
Modafinil is used off-label as a cognitive enhancer or "smart drug" by students and professionals seeking improved focus. Research on cognitive effects in non-sleep-deprived individuals has yielded mixed results. Modafinil is banned in competitive sports by the World Anti-Doping Agency.
Developed in France in the 1970s by neurophysiologist Michel Jouvet, modafinil was approved for medical use in France in 1994 and in the United States in 1998. Generic versions became available in the US in 2012.
What the Community Wants You to Know
Community Wisdom
Tolerance to modafinil appears minimal with occasional use (2-3 times per week or less). Users who take it daily often report diminishing returns within weeks, while those who reserve it for demanding days report consistent effects over years.
228
Myth Busted
Modafinil is widely marketed as a 'smart drug' but experienced users consistently report it is an alertness drug, not a cognitive enhancer. It keeps you awake and focused on monotonous tasks but does not improve creativity, deep thinking, or problem-solving ability.
179
Myth Busted
The idea that modafinil is completely non-addictive is oversimplified. While it binds the dopamine transporter differently from cocaine-like stimulants (it does not reverse dopamine transport), some users develop psychological dependence and report feeling unable to be productive without it after extended daily use.
170
Harm Reduction
General Safety It is strongly recommended that one use harm reduction practices if using this substance. Modafinil has a very favorable safety profile compared to most stimulants. The median lethal do...
Modafinil's effects emerge gradually, typically becoming noticeable forty-five to ninety minutes after oral ingestion. There is no rush, no sudden shift in consciousness. Instead, the change arrives as a quiet subtraction: the usual heaviness of fatigue lifts away, and the fog of drowsiness clears without being replaced by the jittery edge of traditional stimulants. The mind simply feels awake, alert, and ready to engage. It is less like being stimulated and more like being restored to a version of oneself that has had a full night of excellent sleep.
The core of the modafinil experience is a sustained state of focused wakefulness. Attention narrows and stabilizes, making it easier to engage with tasks that would ordinarily feel tedious or overwhelming. There is a subtle increase in motivation, a quiet willingness to begin and persist that smooths the friction of getting started. Working memory feels slightly more accessible, and the ability to hold multiple threads of information in mind improves modestly. The experience lacks the euphoric rush of amphetamines; instead, it offers a clean, functional alertness that many users describe as simply feeling "more like themselves."
Physically, the effects are subtle. Appetite may decrease, and thirst often increases as the compound produces a mild drying effect on mucous membranes. Heart rate may rise slightly, and some people notice a mild headache, particularly if fluid intake is insufficient. There is no significant change in mood beyond the removal of fatigue-related irritability, though some individuals report a faint sense of confidence or optimism. Body temperature may increase marginally, and urination may become more frequent. The physical profile is notably mild compared to other wakefulness-promoting agents.
The duration of effect is long, typically ten to fifteen hours, which makes timing of the dose important to avoid disrupting nighttime sleep. There is no crash or comedown in the traditional sense; rather, the wakefulness simply fades, and normal fatigue signals gradually return. Some people find it difficult to fall asleep even after the subjective effects have worn off, and sleep quality may be reduced on the night following use. The overall experience is utilitarian rather than recreational: modafinil does not feel like a high so much as a quiet mechanical correction, a lifting of the curtain of tiredness to reveal the cognitive baseline underneath.
Subjective Effects
The effects listed below are based on the Subjective Effect Index (SEI), an open research literature based on anecdotal reports and personal analyses. They should be viewed with a healthy degree of skepticism. These effects will not necessarily occur in a predictable or reliable manner, although higher doses are more liable to induce the full spectrum of effects.
Physical Effects
Physical(15)
Appetite suppression— A distinct decrease in hunger and desire to eat, ranging from reduced interest in food to complete d...
Dehydration— A state of insufficient bodily hydration manifesting as persistent thirst, dry mouth, and physical d...
Dizziness— A sensation of spinning, swaying, or lightheadedness that impairs balance and spatial orientation, o...
Dry mouth— A persistent, uncomfortable reduction in saliva production causing the mouth and throat to feel parc...
Headache— A painful sensation of pressure, throbbing, or aching in the head that can range from a dull backgro...
Increased heart rate— A noticeable acceleration of heartbeat that can range from a subtle awareness of one's pulse to a fo...
Insomnia— A persistent inability to fall asleep or maintain sleep despite physical tiredness, often characteri...
Nausea— An uncomfortable sensation of queasiness and stomach discomfort that may or may not lead to vomiting...
Photophobia— An abnormal physical intolerance and sensitivity to light that causes discomfort, squinting, or pain...
Pupil dilation— A visible enlargement of the pupil diameter (mydriasis) that can range from subtle widening to drama...
Respiratory depression— A dangerous slowing and shallowing of breathing that can progress from barely noticeable reductions ...
Seizure— Uncontrolled brain electrical activity causing convulsions and loss of consciousness -- a life-threa...
Stimulation— A state of heightened physical and mental energy characterized by increased wakefulness, elevated mo...
Teeth grinding— An involuntary clenching and rhythmic grinding of the jaw muscles, known clinically as bruxism, that...
Vasoconstriction— A narrowing of blood vessels throughout the body that produces sensations of cold extremities, tingl...
Cognitive & Perceptual Effects
Cognitive(13)
Analysis enhancement— A perceived improvement in one's ability to logically deconstruct concepts, recognize patterns, and ...
Anxiety— Intense feelings of apprehension, worry, and dread that can range from a subtle background unease to...
Anxiety suppression— A partial to complete suppression of anxiety and general unease, producing a calm, relaxed mental st...
Depression— A persistent state of low mood, emotional numbness, hopelessness, and diminished interest or pleasur...
Emotion suppression— A blunting or flattening of emotional experience in which feelings become muted, distant, or seeming...
Community Insights
Community Wisdom(4)
Tolerance to modafinil appears minimal with occasional use (2-3 times per week or less). Users who take it daily often report diminishing returns within weeks, while those who reserve it for demanding days report consistent effects over years.
Based on 3 community posts · 228 combined upvotes
Modafinil is not a substitute for sleep. A four-year daily user found that even taking it only twice a week (Fridays and Saturdays) disrupted sleep quality across all seven days of the week. After stopping entirely, sleep quality, energy, and mental sharpness all improved significantly.
Based on 1 community posts · 122 combined upvotes
Adrafinil is an over-the-counter prodrug that converts to modafinil in the liver. It is legal without prescription in most countries and is a common alternative for those who cannot obtain modafinil. However, the liver conversion adds load on hepatic enzymes, so regular liver function monitoring is advised for chronic use.
Based on 2 community posts · 83 combined upvotes
Modafinil excels at rote, repetitive, and monotonous tasks but is counterproductive for creative work. Users comparing it to LSD microdosing consistently report that modafinil provides a hollow wakefulness without the ideation and flow-state benefits that creative professionals seek.
Based on 2 community posts · 63 combined upvotes
Common Misconceptions(3)
Modafinil is widely marketed as a 'smart drug' but experienced users consistently report it is an alertness drug, not a cognitive enhancer. It keeps you awake and focused on monotonous tasks but does not improve creativity, deep thinking, or problem-solving ability.
Based on 2 community posts · 179 combined upvotes
The idea that modafinil is completely non-addictive is oversimplified. While it binds the dopamine transporter differently from cocaine-like stimulants (it does not reverse dopamine transport), some users develop psychological dependence and report feeling unable to be productive without it after extended daily use.
Based on 2 community posts · 170 combined upvotes
Many newcomers expect modafinil to feel like the drug from the movie Limitless. In reality, the effects are subtle and inconsistent. Some days it works well, other days users feel almost nothing, even at the same dose and with proper sleep and hydration.
Based on 2 community posts · 91 combined upvotes
Harm Reduction(4)
Modafinil can reduce the effectiveness of hormonal contraceptives (birth control pills, patches, rings) by inducing CYP3A4 liver enzymes that break down estrogen and progestin faster. Women using hormonal birth control should use a backup method while taking modafinil and for one month after stopping.
Based on 2 community posts · 156 combined upvotes
Combining modafinil with high-dose caffeine and grapefruit juice is a dangerous stack. One group of students who took 400mg modafinil with 360mg caffeine and grapefruit experienced rapid heart rate, nausea, headache, and severe anxiety lasting over 12 hours. Grapefruit inhibits the same enzymes that metabolize modafinil, potentiating its effects unpredictably.
Based on 1 community posts · 13 combined upvotes
Daily modafinil use at 100-200mg can cause a distinctive and persistent body odor resembling cat urine. The smell comes from sulfur-containing metabolites excreted through sweat. Reducing frequency of use to occasional dosing (a few times per month) appears to prevent this side effect.
Based on 1 community posts · 9 combined upvotes
Stevens-Johnson syndrome (SJS) is a rare but extremely serious reaction to modafinil. If you develop any rash, mouth ulcers, or skin peeling after starting modafinil, stop immediately and seek emergency medical care. One reported case involved a woman who developed severe skin peeling and conjunctivitis after three weeks of alternate-day use.
Based on 1 community posts · 6 combined upvotes
Set & Setting(1)
Taking modafinil too late in the day is the most common beginner mistake. Its half-life is 12-15 hours, meaning a dose taken after noon can easily cause insomnia that night. Experienced users dose first thing in the morning, ideally before 8 AM, to avoid sleep disruption.
Based on 2 community posts · 127 combined upvotes
Dosage Guidance(3)
Many experienced users find that 100mg is the sweet spot rather than the standard 200mg prescription dose. Lower doses provide the wakefulness benefit with fewer side effects like jaw clenching, anxiety, and insomnia. Some users go as low as 50mg and still report meaningful effects.
Based on 2 community posts · 106 combined upvotes
Taking modafinil on an empty stomach hits faster (10-15 minutes for modafinil, 30 minutes for armodafinil) but can cause GI discomfort and nausea. Having a small meal before dosing smooths out the come-up and reduces stomach issues, though onset may be delayed by 30-45 minutes.
Based on 2 community posts · 62 combined upvotes
Armodafinil (the R-enantiomer of modafinil) lasts significantly longer than modafinil, with effects persisting 8-10 hours versus modafinil's 5-7 hours. This makes armodafinil better for full-day tasks but worse if you need to sleep within 8 hours of dosing.
Based on 1 community posts · 49 combined upvotes
Combination Warnings(1)
Mixing modafinil with alcohol produces a deceptive effect: users feel more alert and socially confident while drinking, masking the actual level of intoxication. This can lead to drinking far more than intended. The liver processes both substances through overlapping pathways, increasing hepatic strain.
Based on 2 community posts · 22 combined upvotes
Pharmacology
(R,S)-modafinil, mechanism of action.
Although the exact mechanisms by which modafinil and its R-enantiomer, armodafinil, decrease sleepiness are not fully understood, evidence suggests that these agents promote wakefulness by acting directly or indirectly on many components of the sleep / wake circuit. Modafinil and armodafinil are hypothesized to inhibit GABA and promote dopamine, norepinephrine, histamine, and hypocretin / orexin.
Modafinil and its R-enantiomer, armodafinil, increase both norepinephrine (NE) and dopamine (DA), possibly via their blockade of both the NE and DA reuptake transporters (NET and DAT, respectively). The actions of NE at alpha-adrenergic receptors and DA at dopamine D2 receptors are thought to contribute to the wake-promoting properties of modafinil. Orexin is a key component of the arousal system; thus, the hypothesized action of modafinil on the orexinergic system may help increase alertness. Additionally, modafinil may indirectly increase histamine, either by reducing GABAergic inhibition of histaminergic neurons or via actions at orexinergic neurons. The increase in histamine may contribute to both the wake-promoting effects of modafinil as well as the potential of modafinil to increase alertness.
In genetically engineered mice lacking the dopamine transporter (DAT), modafinil lacked wake-promoting activity, suggesting that this activity was DAT-dependent. However, the wake-promoting effects of modafinil, unlike those of amphetamine, were not reduced by the dopamine receptor antagonisthaloperidol in rats. In addition, alpha-methyl-p-tyrosine, an inhibitor of dopamine synthesis, blocks the action of amphetamine but does not block locomotor activity induced by modafinil.
Detection Methods
Standard Drug Panel Inclusion
Modafinil is a wakefulness-promoting agent that is not detected on standard 5-panel, 10-panel, or 12-panel immunoassay drug screens. It is structurally unrelated to amphetamines and does not cross-react with any standard immunoassay channel. Modafinil is a Schedule IV controlled substance in the United States but is not targeted by any routine workplace or clinical drug testing panel.
Urine Detection
Modafinil and its primary metabolite modafinil acid (modafinilic acid) can be detected in urine for approximately 2 to 4 days after a single dose. Modafinil acid accounts for the majority of urinary excretion (approximately 60 percent). The sulfone metabolite is also detectable. Standard drug screens will not detect modafinil. Detection requires targeted LC-MS/MS analysis.
Blood and Saliva Detection
Modafinil has a plasma half-life of approximately 12 to 15 hours and is detectable in blood for approximately 24 to 48 hours. Oral fluid testing is not routinely used for modafinil. Anti-doping laboratories (WADA) have validated methods for detecting modafinil in blood and urine, as it is on the prohibited list for competitive sports.
Hair Follicle Detection
Hair testing for modafinil is possible with specialized LC-MS/MS methods but is not available through standard commercial laboratories. Anti-doping retrospective hair analysis may include modafinil.
Confirmatory Testing
LC-MS/MS is the definitive method for modafinil identification. Both modafinil and modafinil acid should be targeted. GC-MS can also detect modafinil but may require derivatization for optimal sensitivity. WADA-accredited laboratories have fully validated methods.
Reagent Testing
Standard reagent tests (Marquis, Mecke, Mandelin) are not useful for modafinil identification, as the compound does not produce characteristic color reactions. Modafinil is typically encountered as pharmaceutical tablets with distinctive markings, making visual identification more practical than reagent testing for this substance.
“Mixing modafinil with alcohol produces a deceptive effect: users feel more alert and socially confident while drinking, masking the actual level of intoxication. This can lead to drinking far more than intended. The liver processes both substances through overlapping pathways, increasing hepatic strain.”
“Combining modafinil with high-dose caffeine and grapefruit juice is a dangerous stack. One group of students who took 400mg modafinil with 360mg caffeine and grapefruit experienced rapid heart rate, nausea, headache, and severe anxiety lasting over 12 hours. Grapefruit inhibits the same enzymes that metabolize modafinil, potentiating its effects unpredictably.”
Modafinil was originally developed in France by neurophysiologist professor Michel Jouvet and Lafon Laboratories. Modafinil originated with the late 1970s invention of a series of benzhydryl sulfinyl compounds, including adrafinil, which was first offered as an experimental treatment for narcolepsy in France in 1986. Modafinil is the primary metabolite of adrafinil, lacking the polar -OH group on its terminal amide, and has similar activity to the parent drug but is much more widely used. It has been prescribed in France since 1994 under the name Modiodal, and in the US since 1998 as Provigil.
Reagent Testing
To find out whether a substance is likely to be modafinil, reagent testing kits can be used. Application of different reagents to the same substance may cause specific color changes to appear. Reagent tests do not guarantee that a substance is pure. To test purity of a substance, consider thin layer chromatography (TLC) or gas chromatography.
Legal Status
Austria: Modafinil is classed as NR (prescription only, repeated dispense prohibited)
Canada: Modafinil is listed as a Schedule F prescription drug and can be prescribed for human and veterinary use
Germany: Modafinil is a prescription medicine, according to Anlage 1 AMVV
Russian Federation: Modafinil is classed as a Schedule II substance
Switzerland: Modafinil is listed as a "Abgabekategorie B" pharmaceutical, which requires a prescription
United Kingdom: Modafinil is a licensed prescription-only medicine (POM). It is not a criminal offence to possess this medicine without a valid prescription. It can legally be obtained through legal import for personal use as outlined in Section 13 of the Medicines Act 1968
United States: Modafinil is a Schedule IV controlled substance. It is illegal to buy, sell, or possess the drug without a prescription or DEA license. Notably, the Controlled Substances Act analogue provisions only cover Schedule I and II substances, which means that modafinil analogues (such as adrafinil and fluorafinil) occupy a legal gray area and are sold by nootropic vendors without prescription requirements
Harm Reduction
General Safety
It is strongly recommended that one use harm reduction practices if using this substance. Modafinil has a very favorable safety profile compared to most stimulants. The median lethal dose (LD50) for human beings has never been reached. No life-threatening effects have taken place in clinical trials involving the administration of 1000 mg to 1600 mg per day for 7 to 21 consecutive days. Intentional acute overdoses of 4500 mg and 4000 mg in two adult subjects, and an accidental ingestion of 800 mg by a three-year-old child, did not result in any life-threatening effects or death.
Tolerance and Dependence
Modafinil is generally considered not addictive, with a low potential for abuse. It does not seem to be capable of causing psychological dependence among most users. Tolerance develops with prolonged and repeated use, requiring increasingly large doses to achieve the same effects. After cessation, it takes approximately 3-7 days to 1-2 weeks to return to baseline. Modafinil may present cross-tolerance with other benzhydryl nootropics, meaning that after consumption of modafinil, related eugeroic compounds such as armodafinil and adrafinil will display a reduced effect.
However, community experience from long-term users (4+ years of regular use) suggests that chronic modafinil use may mask underlying issues rather than resolve them. Some users report that after years of daily use, they realized modafinil was compensating for poor sleep habits, undiagnosed sleep disorders, or other root causes of fatigue. Several community members advocate for investigating fundamental causes of fatigue (such as sleep apnea, nutritional deficiencies, methylation issues, or histamine dysregulation) rather than relying indefinitely on modafinil.
Drug Interactions
Hormonal Birth Control -- Modafinil reduces the effectiveness of hormonal birth control for up to a month after use by increasing the activity of the enzyme CYP3A4/5. This is a critical interaction that many users are unaware of. Alternative contraception methods should be used during modafinil use and for at least one month after discontinuation.
CYP2C19 Substrates -- Modafinil may prolong the elimination of some anxiolytics like diazepam, propranolol, and clomipramine, resulting in higher systemic exposure to those drugs.
Omeprazole -- Although modafinil may cause nausea and acid reflux, it should not be taken together with omeprazole (which is a CYP2C19 substrate).
Caffeine -- While commonly combined, high doses of caffeine with modafinil can produce uncomfortable symptoms including rapid heartbeat, nausea, headache, difficulty sitting still, and a sensation of time passing very quickly. Community reports describe cases where the combination of 400+ mg caffeine with standard modafinil doses produced distressing cardiovascular symptoms lasting many hours. Users should moderate caffeine intake when using modafinil.
Alcohol -- Some users report that modafinil taken earlier in the day can interact with alcohol consumed in the evening, producing enhanced sociability and talkativeness but potentially masking alcohol's sedative effects, leading to overconsumption.
Practical Tips
Take modafinil early in the day (morning) to avoid insomnia. The long half-life (12-15 hours) means evening doses will significantly disrupt sleep.
Start with 100 mg rather than the standard 200 mg prescription dose; many users find lower doses effective with fewer side effects.
Stay well-hydrated, as modafinil can cause dehydration.
Be aware that modafinil can cause a distinctive body odor in some users, described as a strong, ammonia-like or "cat urine" smell, particularly with daily use at higher doses. This side effect is dose-dependent and resolves with discontinuation or dose reduction.
Toxicity & Safety
The long-term safety and effectiveness of modafinil as a drug of regular usage have not been determined.
Anecdotal reports from people who have tried modafinil suggest that there do not seem to be any negative health effects attributed to simply trying this substance at low to moderate doses by itself or using it sparingly (but nothing can be completely guaranteed).
It is worth noting that as this compound is a commonly prescribed pharmaceutical, it is considerably less likely to have unpredictable adverse health effects than the typical research chemical. Nevertheless, it is strongly recommended that one use harm reduction practices if using this substance.
Lethal dosage
The median lethal dose at which 50% of participants die (LD50) from modafinil for human beings has never been reached. No life-threatening effects have taken place in clinical trials involving the administration of 1000mg to 1600mg of modafinil per day for 7 to 21 consecutive days. Intentional acute overdoses of 4500mg and 4000mg in two adult subjects and an accidental ingestion of 800mg by a three-year-old child did not result in any life-threatening effects or death. After overdosing on 5000mg of modafinil in a suicide attempt, a fifteen-year-old female reported a severe headache, nausea, and tachycardia, but did not appear to have any lethal or long-term effects.
Tolerance and addiction potential
The chronic use of modafinil can be considered as not addictive with a low potential for abuse. It does not seem to be capable of causing psychological dependence among most users.
Tolerance to many of the effects of modafinil develops with prolonged and repeated use. This results in users having to administer increasingly large doses to achieve the same effects. After that, it takes about 3 - 7 days for the tolerance to be reduced to half and 1 - 2 weeks to be back at baseline (in the absence of further consumption). Modafinil may present a cross-tolerance with all benzhydryl nootropics, meaning that after the consumption of modafinil, all related eugeroic compounds such as armodafinil and adrafinil will display a reduced effect.
Dangerous interactions
Warning: Many psychoactive substances that are reasonably safe to use on their own can suddenly become dangerous and even life-threatening when combined with certain other substances. The following list provides some known dangerous interactions (although it is not guaranteed to include all of them).
Always conduct independent research (e.g. Google, DuckDuckGo, PubMed) to ensure that a combination of two or more substances is safe to consume. Some of the listed interactions have been sourced from TripSit.
25x-NBOMe & 25x-NBOH - 25x compounds are highly stimulating and physically straining. Combinations with Modafinil should be strictly avoided due to the risk of excessive stimulation and heart strain. This can result in increased blood pressure, vasoconstriction, panic attacks, thought loops, seizures, and heart failure in extreme cases.
Alcohol - Combining alcohol with stimulants can be dangerous due to the risk of accidental over-intoxication. Stimulants mask alcohol's depressant effects, which is what most people use to assess their degree of intoxication. Once the stimulant wears off, the depressant effects will be left unopposed, which can result in blackouts and severe respiratory depression. If mixing, the user should strictly limit themselves to only drinking a certain amount of alcohol per hour.
MDMA - Any neurotoxic effects of MDMA are likely to be increased when other stimulants are present. There is also a risk of excessive blood pressure and heart strain (cardiotoxicity).
MXE - Some reports suggest combinations with MXE may dangerously increase blood pressure and increase the risk of mania and psychosis.
Dissociatives - Both classes carry a risk of delusions, mania and psychosis, and these risk may be multiplied when combined.
Stimulants - Modafinil may be dangerous to combine with other stimulants like cocaine as they can increase one's heart rate and blood pressure to dangerous levels.
Tramadol - Tramadol is known to lower the seizure threshold and combinations with stimulants may further increase this risk.
MAOIs - This combination may increase the amount of neurotransmitters such as dopamine to dangerous or even fatal levels. Examples include syrian rue, banisteriopsis caapi, and some antidepressants.
Hormonal Birth Control - Modafinil reduces the effectiveness of hormonal birth control for up to a month after use by increasing the activity of the enzyme CYP3A4/5. Notably, the same enzyme is inhibited by grapefruit juice.
CYP2C19-substrates - Modafinil may prolonge the elimation of some anxyolitics like diazepam, propranolol and clomipramine, resulting in higher systemic exposure to those drugs.
Although Modafinil may cause nausea and acid reflex, it should not be taken together with omeprazole (which is a CYP2C19-substrate).
Addiction Potential
not addictive with a low potential for abuse
Overdose Information
Acute Overdose
The median lethal dose (LD50) from modafinil for human beings has never been reached, indicating a remarkably wide safety margin. No life-threatening effects have taken place in clinical trials involving the administration of 1000 mg to 1600 mg per day for 7 to 21 consecutive days. Intentional acute overdoses of 4500 mg and 4000 mg in two adult subjects, and an accidental ingestion of 800 mg by a three-year-old child, did not result in any life-threatening effects or death. After overdosing on 5000 mg of modafinil in a suicide attempt, a fifteen-year-old female reported a severe headache, nausea, and tachycardia, but did not appear to have any lethal or long-term effects.
Overdose Symptoms
At supratherapeutic doses, the most commonly reported symptoms include:
Modafinil overdose is managed with supportive care. There is no specific antidote. In cases of significant overdose, cardiovascular monitoring is appropriate. Benzodiazepines may be used to manage anxiety and insomnia resulting from overdose. Due to the long half-life, symptoms may persist for 12-24 hours or longer.
Combination Risks
While modafinil alone has an excellent safety record, combinations with other stimulants should be approached with caution. Community reports include a case of seizure following the combination of modafinil with methylcyclazodone (a potent eugeroic), heavy caffeine consumption, and cannabis. Users who stack multiple wakefulness-promoting agents or combine modafinil with high doses of caffeine should be aware of the potential for additive cardiovascular stress and possible lowering of the seizure threshold.
Disruption of sleep architecture from chronic modafinil use combined with other wakefulness agents can lead to severe cumulative sleep deprivation. One community report describes a user who stayed awake for approximately 48 hours using modafinil combined with prescribed medications, followed by a prolonged rebound sleep period of nearly 48 hours, illustrating the risks of sustained wakefulness.
Call emergency services if symptoms include chest pain, severe tachycardia, seizures, or loss of consciousness. Good Samaritan laws apply.
Dangerous Interactions
The combinations listed below may be life-threatening. Independent research should always be conducted to ensure safety when combining substances.
Risk of hypertensive crisis and serotonin syndrome; potentially fatal combination
Tolerance
Full
develops with prolonged and repeated use
Half
3 - 7 days
Zero
1 - 2 weeks
Cross-tolerances
benzhydryl, nootropic|nootropics
Legal Status
Modafinil is legally approved for medical purposes worldwide. However, it is illegal to sell and possess in most countries without a prescription.
Australia:** Modafinil is listed as a Schedule 4 (prescription only) drug in Australia and it can be prescribed for sleep apnea and narcolepsy.
Austria:** Modafinil is classed as NR (prescription only, repeated dispense prohibited)
Canada:** Modafinil is listed as a Schedule F prescription drug in Canada and can be prescribed for human and veterinary use.
Germany:** Modafinil is a prescription medicine, according to Anlage 1 AMVV.
Russian Federation:** Modafinil is classed as a Schedule II substance.
Switzerland:** Modafinil is listed as a "Abgabekategorie B" pharmaceutical, which requires a prescription.
United Kingdom:** Modafinil is a licensed prescription-only medicine (POM) in the United Kingdom. It is not a criminal offence to possess this medicine without a valid prescription. This medicine can legally be obtained with a valid prescription or through legal import of the medicine for personal use as outlined in Section 13 of the Medicines Act 1968.
United States:** In the United States, modafinil is a Schedule IV controlled substance. It is illegal to buy, sell, or possess the drug without a prescription or DEA license.
In rare cases, modafinil can trigger Stevens-Johnson Syndrome, a serious skin reaction. If you develop a rash, mouth sores, or skin blistering after starting modafinil, stop immediately and seek emergency medical attention.
ModaSkinAlert · Mar 4
Modafinil is an alertness drug, not a smart drug. After years of use, many people realize it keeps you awake and focused but does not actually enhance intelligence or creativity. Set expectations accordingly.
ModaRealist · Mar 4
Modafinil reduces the effectiveness of hormonal birth control (pills, patches, implants). Use backup contraception while taking modafinil and for one month after stopping. This interaction is frequently overlooked.
ContraceptWarn · Mar 4
Before relying on modafinil for chronic fatigue, investigate underlying causes like sleep apnea, thyroid issues, vitamin deficiencies, or poor sleep hygiene. Modafinil can mask symptoms while the root problem worsens.
RootCauseFixer · Mar 4
In very rare cases, modafinil can cause Stevens-Johnson syndrome, a serious skin reaction. If you develop a rash, hives, blisters, or mouth sores after taking modafinil, stop immediately and seek medical attention.
SJSwarning · Mar 4
Many users find 50-100mg of modafinil sufficient. The standard 200mg dose can cause anxiety, headaches, and insomnia in sensitive individuals. Start low and find your minimum effective dose.
After four years of modafinil use, the author concludes it is an alertness drug rather than a cognitive enhancer and believes it may have negatively impacted their ability to think deeply during off periods. They advocate for proper sleep and addressing root causes of fatigue rather than chemical masking.
A user suffering from chronic fatigue discovers through 23andMe genetic analysis that a COMT+/+ variant may cause low histamine levels, resolving their symptoms with antihistamine supplementation rather than modafinil or other stimulants. The post shares a personal breakthrough relevant to others who have not found relief through conventional nootropics.
A user shares research on modafinil's atypical dopamine transporter binding mechanism compared to cocaine-like inhibitors such as methylphenidate, asking whether this makes it a genuinely non-addictive ADHD treatment. The discussion explores the pharmacological differences between stimulant classes.
A user who has used Ritalin (60mg extended-release) on workdays for two years asks about long-term risks while noting significant improvements in social and academic functioning. The post seeks reassurance and evidence-based perspectives on chronic methylphenidate use.
A middle-aged user reviews several nootropic substances trialed in 2017, sharing observations on cognitive effects, tolerability, and overall utility from a thoughtful, non-recreational perspective. The post provides a balanced multi-substance retrospective useful for those exploring cognitive enhancement.
A user asks whether conscientiousness, like IQ, can be pharmacologically enhanced, noting that long-term modafinil and Adderall users have sometimes reported sustained improvements in this trait. The discussion explores the limits of nootropic enhancement and the distinction between cognitive and personality modification.
An 18-year-old newly diagnosed with ADHD asks whether to request modafinil or armodafinil alongside their newly prescribed Ritalin, noting their psychiatrist was reluctant to prescribe stimulants. The post raises questions about modafinil's suitability as an ADHD adjunct.
A PhD student at London South Bank University recruits non-ADHD modafinil and methylphenidate users for a research survey on everyday attention and drug use. The post is straightforward academic recruitment.
Wakefulness-promoting medication Modafinil, sold under the brand name Provigil among others, is a central nervous system (CNS) stimulant medication used to treat narcolepsy, sleep apnea, and shift work sleep disorder. It is taken by mouth. Modafinil is a first-line treatment for narcolepsy in the Un
What are the effects of Modafinil?
Modafinil's effects emerge gradually, typically becoming noticeable forty-five to ninety minutes after oral ingestion. There is no rush, no sudden shift in consciousness. Instead, the change arrives as a quiet subtraction: the usual heaviness of fatigue lifts away, and the fog of drowsiness clears w
Is Modafinil addictive?
not addictive with a low potential for abuse
What are the risks of Modafinil?
The long-term safety and effectiveness of modafinil as a drug of regular usage have not been determined. Anecdotal reports from people who have tried modafinil suggest that there do not seem to be any negative health effects attributed to simply trying this substance at low to moderate doses by itse
How long does Modafinil last?
The total duration of Modafinil via oral is 5 hours to 10 hours. Onset typically occurs within 20 minutes to 1 hour. Peak effects last 3.5 hours to 5 hours.
Focus enhancement— An enhanced ability to direct and sustain attention on a single task or stimulus with unusual clarit...
Mania— Abnormally elevated mood, energy, and activity with impulsive behavior and grandiosity, associated w...
Motivation enhancement— A heightened sense of drive, ambition, and willingness to accomplish tasks, making productive effort...
Sleepiness— A progressive onset of drowsiness, heaviness, and the desire to sleep that pulls the individual towa...
Thought acceleration— The experience of thoughts occurring at a dramatically increased rate, as if the mind has been shift...
Thought loops— Becoming trapped in a repeating cycle of thoughts, actions, and emotions that loops every few second...
Time distortion— Subjective perception of time becomes dramatically altered — minutes may feel like hours, or hours p...
Wakefulness— An increased ability to stay awake and alert without the desire to sleep. Distinct from stimulation ...
